Graciela Muniz-Terrera

Graciela Muniz-Terrera

Auto-generated profile, based on publicly available information

Graciela Muniz-Terrera

Ohio University

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2015 in International Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
RMRiccardo E Marioni
Riccardo E Marioni
SSSonia Shah
Sonia Shah
AMAllan F McRae
Allan F McRae
SRStuart J Ritchie
Stuart J Ritchie
GMGraciela Muniz-Terrera
Graciela Muniz-Terrera
IDIan Deary
Ian Deary
Background: The DNA methylation-based ‘epigenetic clock’ correlates strongly with chronological age, but it is currently unclear what drives individual differences. We examine cross-sectional and longitudinal associations between the epigenetic clock and four mortality-linked markers of physical and mental fitness: lung function, walking speed, grip strength and cognitive ability. Methods: DNA methylation-based age acceleration (residuals of the epigenetic clock estimate regressed on chronological age) were estimated in the Lothian Birth Cohort 1936 at ages 70 (n = 920), 73 (n = 299) and 76 (n = 273) years. General cognitive ability, walking speed, lung function and grip strength were measured concurrently. Cross-sectional correlations between age acceleration and the fitness variables were calculated. Longitudinal change in the epigenetic clock estimates and the fitness variables were assessed via linear mixed models and latent growth curves. Epigenetic age acceleration at age 70 was used as a predictor of longitudinal change in fitness. Epigenome-wide association studies (EWASs) were conducted on the four fitness measures. Results: Cross-sectional correlations were significant between greater age acceleration and poorer performance on the lung function, cognition and grip strength measures (r range: −0.07 to −0.05, P range: 9.7 x 10−3 to 0.024). All of the fitness variables declined over time but age acceleration did not correlate with subsequent change over 6 years. There were no EWAS hits for the fitness traits. Conclusions: Markers of physical and mental fitness are associated with the epigenetic clock (lower abilities associated with age acceleration). However, age acceleration does not associate with decline in these measures, at least over a relatively short follow-up.

9 August 2012 in Brain
Verified
Journal Article
Open access
PDF file
DDDaniel H. J. Davis
Daniel H. J. Davis
GTGraciela Muniz Terrera
Graciela Muniz Terrera
HKHannah Keage
Hannah Keage
TRTerhi Rahkonen
Terhi Rahkonen
MOMinna Oinas
Minna Oinas
CBCarol Brayne
Carol Brayne
Recent studies suggest that delirium is associated with risk of dementia and also acceleration of decline in existing dementia. However, previous studies may have been confounded by incomplete ascertainment of cognitive status at baseline. Herein, we used a true population sample to determine if delirium is a risk factor for incident dementia and cognitive decline. We also examined the effect of delirium at the pathological level by determining associations between dementia and neuropathological markers of dementia in patients with and without a history of delirium. The Vantaa 85+ study examined 553 individuals (92% of those eligible) aged ≥85 years at baseline, 3, 5, 8 and 10 years. Brain autopsy was performed in 52%. Fixed and random-effects regression models were used to assess associations between (i) delirium and incident dementia and (ii) decline in Mini-Mental State Examination scores in the whole group. The relationship between dementia and common neuropathological markers (Alzheimer-type, infarcts and Lewy-body) was modelled, stratified by history of delirium. Delirium increased the risk of incident dementia (odds ratio 8.7, 95% confidence interval 2.1–35). Delirium was also associated with worsening dementia severity (odds ratio 3.1, 95% confidence interval 1.5–6.3) as well as deterioration in global function score (odds ratio 2.8, 95% confidence interval 1.4–5.5). In the whole study population, delirium was associated with loss of 1.0 more Mini-Mental State Examination points per year (95% confidence interval 0.11–1.89) than those with no history of delirium. In individuals with dementia and no history of delirium (n = 232), all pathologies were significantly associated with dementia. However, in individuals with delirium and dementia (n = 58), no relationship between dementia and these markers was found. For example, higher Braak stage was associated with dementia when no history of delirium (odds ratio 2.0, 95% confidence interval 1.1–3.5, P = 0.02), but in those with a history of delirium, there was no significant relationship (odds ratio 1.2, 95% confidence interval 0.2–6.7, P = 0.85). This trend for odds ratios to be closer to unity in the delirium and dementia group was observed for neuritic amyloid, apolipoprotein ε status, presence of infarcts, α-synucleinopathy and neuronal loss in substantia nigra. These findings are the first to demonstrate in a true population study that delirium is a strong risk factor for incident dementia and cognitive decline in the oldest-old. However, in this study, the relationship did not appear to be mediated by classical neuropathologies associated with dementia.

13 December 2018 in Alzheimer's & Dementia
Verified
Journal Article
Open access
GBGanesh M. Babulal
Ganesh M. Babulal
YQYakeel T. Quiroz
Yakeel T. Quiroz
BABenedict C. Albensi
Benedict C. Albensi
EAEider Arenaza‐Urquijo
Eider Arenaza‐Urquijo
AAArlene J. Astell
Arlene J. Astell
SOSid O'bryant
Sid O'bryant
Alzheimer's disease and related dementias (ADRDs) are a global crisis facing the aging population and society as a whole. With the numbers of people with ADRDs predicted to rise dramatically across the world, the scientific community can no longer neglect the need for research focusing on ADRDs among underrepresented ethnoracial diverse groups. The Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART; alz.org/ISTAART ) comprises a number of professional interest areas (PIAs), each focusing on a major scientific area associated with ADRDs. We leverage the expertise of the existing international cadre of ISTAART scientists and experts to synthesize a cross‐PIA white paper that provides both a concise “state‐of‐the‐science” report of ethnoracial factors across PIA foci and updated recommendations to address immediate needs to advance ADRD science across ethnoracial populations.

12 July 2010 in Archives of internal medicine (1960)
Verified
Journal Article
Open access
PDF file
DLDavid J. Llewellyn
David J. Llewellyn
ILIain A. Lang
Iain A. Lang
KLKenneth M. Langa
Kenneth M. Langa
GMGraciela Muniz-Terrera
Graciela Muniz-Terrera
CPCaroline L. Phillips
Caroline L. Phillips
DMDavid Melzer
David Melzer
It is estimated that between 40% and 100% of older, community-living adults in the United States and Europe are vitamin D deficient.1 Vitamin D deficiency is associated with fractures, various chronic conditions, and mortality.2-5 Cognitive decline and dementia are also common in older adults, although their causes remain unclear.6-8 Vitamin D may help to prevent neurodegeneration because it plays an important role in the expression of neurotrophic factors, neurogenesis, calcium homeostasis, detoxification, and β-amyloid clearance.9-11

5 July 2017 in BMJ
Verified
Journal Article
Open access
PDF file
SASara Ahmadi-Abhari
Sara Ahmadi-Abhari
MGMaria Guzman-Castillo
Maria Guzman-Castillo
PBPiotr Bandosz
Piotr Bandosz
MSMartin J Shipley
Martin J Shipley
GMGraciela Muniz-Terrera
Graciela Muniz-Terrera
EBEric J Brunner
Eric J Brunner
Objective To forecast dementia prevalence with a dynamic modelling approach that integrates calendar trends in dementia incidence with those for mortality and cardiovascular disease. Design Modelling study. Setting General adult population of England and Wales. Participants The English Longitudinal Study of Ageing (ELSA) is a representative panel study with six waves of data across 2002-13. Men and women aged 50 or more years, selected randomly, and their cohabiting partners were recruited to the first wave of ELSA (2002-03). 11392 adults participated (response rate 67%). To maintain representativeness, refreshment participants were recruited to the study at subsequent waves. The total analytical sample constituted 17 906 people. Constant objective criteria based on cognitive and functional impairment were used to ascertain dementia cases at each wave. Main outcome measures To estimate calendar trends in dementia incidence, correcting for bias due to loss to follow-up of study participants, a joint model of longitudinal and time-to-event data was fitted to ELSA data. To forecast future dementia prevalence, the probabilistic Markov model IMPACT-BAM (IMPACT-Better Ageing Model) was developed. IMPACT-BAM models transitions of the population aged 35 or more years through states of cardiovascular disease, cognitive and functional impairment, and dementia, to death. It enables prediction of dementia prevalence while accounting for the growing pool of susceptible people as a result of increased life expectancy and the competing effects due to changes in mortality, and incidence of cardiovascular disease. Results In ELSA, dementia incidence was estimated at 14.3 per 1000 person years in men and 17.0/1000 person years in women aged 50 or more in 2010. Dementia incidence declined at a relative rate of 2.7% (95% confidence interval 2.4% to 2.9%) for each year during 2002-13. Using IMPACT-BAM, we estimated there were approximately 767 000 (95% uncertainty interval 735 000 to 797 000) people with dementia in England and Wales in 2016. Despite the decrease in incidence and age specific prevalence, the number of people with dementia is projected to increase to 872 000, 1 092 000, and 1 205 000 in 2020, 2030, and 2040, respectively. A sensitivity analysis without the incidence decline gave a much larger projected growth, of more than 1.9 million people with dementia in 2040. Conclusions Age specific dementia incidence is declining. The number of people with dementia in England and Wales is likely to increase by 57% from 2016 to 2040. This increase is mainly driven by improved life expectancy.

1 March 2017 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
DDDaniel H. J. Davis
Daniel H. J. Davis
GMGraciela Muniz-Terrera
Graciela Muniz-Terrera
HKHannah Keage
Hannah Keage
BSBlossom C. M. Stephan
Blossom C. M. Stephan
JFJane Fleming
Jane Fleming
FMfor the Epidemiological Clinicopathological Studies in Europe (EClipSE) Collaborative Members
for the Epidemiological Clinicopathological Studies in Europe (EClipSE) Collaborative Members
Understanding the pathologic basis of cognitive impairment in whole populations is a prerequisite to mitigating the increasing public health burden of dementia.1 Many strands of investigation presuppose that Alzheimer, vascular, and Lewy body pathologic features are the predominant causes of dementia. This paradigm has directed the search for biomarkers, treatments, and potential prevention strategies. However, evidence indicates that these classic pathologic processes do not fully account for the clinical syndrome,2 especially in unselected populations of the oldest-old.3,4 For example, older people may have a large burden of the pathologic processes of classic dementia but no associated clinical dementia and vice versa.